Elizabeth Jeans, MD
Radiation Oncology · Scottsdale, AZNPI 1154852135
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,653 of the $2,743 with a category attached, or 60.3%. 16 manufacturers reported payments, led by GT Medical Technologies, Inc at 52.9% of the total. 2025 is the largest year on record at $1,864, more than ten times the $119 reported in 2022.
Across 31 payments — averaging $88.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GT Medical Technologies, Inc$1K
- Novocure Inc.$174
- Visionrt, Inc.$170
- Telix Pharmaceuticals$139
- Intuitive Surgical$131
- Monteris Medical Corporation$114
- plus $565 from 10 others
What the payments were for
- Travel & lodging$1,09040%
- Food & beverage$1,65360%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GT Medical Technologies, Inc | 6 | $1,451 |
| Novocure Inc. | 1 | $174 |
| Visionrt, Inc. | 1 | $170 |
| Telix Pharmaceuticals | 1 | $139 |
| Intuitive Surgical | 1 | $131 |
| Monteris Medical Corporation | 1 | $114 |
| Progenics Pharmaceuticals, Inc. | 4 | $101 |
| Pfizer | 2 | $100 |
| GE HealthCare | 2 | $65 |
| AbbVie | 3 | $63 |
| Sobi, Inc | 2 | $57 |
| Boston Scientific | 2 | $52 |
| Daiichi Sankyo Inc. | 2 | $46 |
| Blue Earth Diagnostics | 1 | $32 |
| Incyte Corporation | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GammaTile$1,293
- ILLUCCIX$278
- Optune$174
- Da Vinci Surgical System$131
- Neuroblate$114
How this compares
$2,743 in reported general payments places this provider in the 60th percentile of 138 radiation oncology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mometasone Furoate | 38 | $693 |
| Tamsulosin Hcl | 41 | $412 |
| Dexamethasone | 18 | $281 |
| Gabapentin | 12 | $145 |
| Silver Sulfadiazine | 16 | $112 |
| Oxycodone Hcl | 16 | $77 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Scottsdale
- Carlos VargasScottsdale$22K
- Vershalee ShuklaScottsdale$19K
- Aaron AmbradScottsdale$18K
- Terence SioScottsdale$15K
- Gordon GradoScottsdale$12K
- Gregory MaggassScottsdale$11K
- Scott TannehillScottsdale$8K
- Randa TaoScottsdale$6K
- Apar GuptaScottsdale$6K
- Chi ZhangScottsdale$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.